Manufacturing Transition. As soon as practicable after the termination of this Agreement, Supplier shall also provide Purchaser with technical assistance reasonably requested by Purchaser to transition manufacturing of Licensed Adjuvants to Purchaser (or to Third Party manufacturers designated by Purchaser) including, without limitation, (A) making THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. arrangements for Purchaser or its designee to observe Supplier’s existing manufacturing and testing processes, (B) making appropriate personnel available to Purchaser at reasonable times and places upon reasonable notice for the purpose of assisting Purchaser to understand and use the know-how described in this Section 6.3 to establish fully functional and cGMP compliant production facilities for the manufacture of Licensed Adjuvants, and (C) transitioning to Purchaser relationships with any Third Party supplier, vendors and contractors, to the extent such relationships are necessary or useful for the manufacture of Licensed Adjuvants, including the assignment to Purchaser, if legally possible, of contracts between Supplier and such Third Party supplier, vendors and contractors; provided, however, that Supplier shall not be obliged transfer or assign any relationships with Third Party supplier, vendors and contractors for commodity services or products generally available on the market.
Manufacturing Transition. (I) Upon Amgen providing a written notice to ViaCell of Amgen exercising its rights to assume the rights and obligations of the Manufacturing Lead pursuant to Section 7.2(f) or 4.6 with respect to a Collaboration Product (a "Manufacturing Transition Notice"), ViaCell shall promptly provide to Amgen all information, Materials and ViaCell Know-How as may be useful or necessary to facilitate Amgen's manufacture of that Collaboration Product.
Manufacturing Transition. Consistent with the agreement referenced in Section 3.01(a)(ix) to be entered into between Pillsbury and Seller, Seller agrees that it will cease manufacturing any of the Harvest Burger Products under the Green Giant label as soon as Buyer provides to Seller the new packaging materials for the Harvest Burger Products. Seller agrees to use its best efforts to ensure an orderly transition of the manufacture of the Harvest Burger Products for Pillsbury to Buyer as soon as is reasonably practicable. Seller acknowledges and agrees that Buyer shall have no obligations relating to any of the Inventory or any Harvest Burger Products that were manufactured by Seller for Pillsbury. Seller agrees to promptly notify Pillsbury at such time as Buyer delivers new packaging materials for the Harvest Burger Products and advise Pillsbury that, following such date, Seller shall no longer supply Products to Pillsbury.
Manufacturing Transition. As soon as practicable following the Effective Date, the Parties shall meet to develop a detailed plan regarding the transition of manufacturing responsibilities from Celltech to Pharmacia. The Parties shall use all reasonable and diligent efforts to cooperate with each other to ensure a smooth transition of manufacturing to Pharmacia. *.
Manufacturing Transition. The Parties acknowledge that Endocyte may be required to engage additional Third Parties during the Term to Manufacture the Compound and/or Product (each, a “CMO”) in order to meet global commercial demand for such Compound and/or Product. If Endocyte notifies ABX that it desires to engage any CMO to Manufacture the Compound and/or Product, or if at any time it becomes known to the Parties that ABX will cease to be the Manufacturer of the Compound or Product for any reason, including termination of the Supply Agreement in accordance with the terms thereof, then as far in advance of such engagement or cessation as may be reasonably requested by Endocyte, the Parties shall cooperate to enable each such CMO or Endocyte, as applicable, to assume all or a portion of the Manufacturing, directly or through a Third Party (in either case, a “Successor Manufacturer”), of the Compound and, if applicable, the Product. In such case, ABX shall cooperate fully and in good faith to enable the Successor Manufacturer to assume all or a portion of the Manufacturing of the Compound and, if applicable, the Product, including:
Manufacturing Transition. (a) At any time during the Term, Menarini may elect (by written notice to VIVUS) either of the following: (a) to accept an assignment of VIVUS’s agreements with the manufacture(s) then part of the supply chain for Product for use in the Field in the Menarini Territory (such option, “Supply Chain Transfer”) or (b) to manufacture, itself or through *** Third Party manufacturers, Compound and/or bulk tablets of Product for use by Menarini, its Affiliates, and/or its sublicensees in the Field in the Menarini Territory (such option, “Independent Manufacturing”). Notwithstanding Menarini’s election to initiate Independent Manufacturing, the Commercial Supply Agreement shall continue in full force and effect, and Menarini may trigger the Supply Chain Transfer at a later date. Similarly, if Menarini triggers the Supply Chain Transfer, Menarini shall retain the right to initiate Independent Manufacturing at a later date, but Menarini’s right to manufacture Product shall be subject to the limitation set forth in Section 2.2(b)(ii).
Manufacturing Transition
